Reply to: “Comment on ‘Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study’”

Andrea Chiricozzi; T. Torres

doi:10.1016/j.jaad.2019.05.032

Reply to: “Comment on ‘Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study’”

Centro Hospitalar Universitário do Porto

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Lingua originale	English
pagine (da-a)	e83-E83
Rivista	Journal of the American Academy of Dermatology
Volume	81
DOI	https://doi.org/10.1016/j.jaad.2019.05.032
Stato di pubblicazione	Pubblicato - 2019

Keywords

psoriasis

Accesso al documento

10.1016/j.jaad.2019.05.032

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{6907295b1cc04eec856a77c54de78de8,

title = "Reply to: “Comment on {\textquoteleft}Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study{\textquoteright}”",

keywords = "psoriasis, psoriasis",

author = "Andrea Chiricozzi and T. Torres",

year = "2019",

doi = "10.1016/j.jaad.2019.05.032",

language = "English",

volume = "81",

pages = "e83--E83",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Mosby Year Book Incorporated:6277 Sea Harbor Drive:Orlando, FL 32887:(800)654-2452, (407)345-4000, EMAIL: hhspcs@harcourt.com, INTERNET: http://www.mosby.com, Fax: (407)363-9661, (314)432-1380",

}

TY - JOUR

T1 - Reply to: “Comment on ‘Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study’”

AU - Chiricozzi, Andrea

AU - Torres, T.

PY - 2019

Y1 - 2019

KW - psoriasis

UR - http://hdl.handle.net/10807/213930

U2 - 10.1016/j.jaad.2019.05.032

DO - 10.1016/j.jaad.2019.05.032

M3 - Article

SN - 0190-9622

VL - 81

SP - e83-E83

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

ER -